$CBIO
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Joshua T. Brumm
CEO
33
Employees
$16.89
Current Price
$260.41M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 9 | $285,500.96 | 16,726 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 9 | $285,500.96 | 16,726 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 9 | $285,500.96 | 16,726 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 7 | 9 | $285,500.96 | 16,726 | ||
| 3 months | Buys | 1 | 1 | $12,375,025.00 | 853,450 | 43.34:1 |
| Sells | 7 | 9 | $285,500.96 | 16,726 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: